Ocular Hemorrhage Attributed to COVID-19 Vaccination

Written by Peter A. Mccullough, MD, MPH on August 26, 2024. Posted in Current News

In clinical practice I have seen a range of ocular pathologies in patients after COVID-19 vaccination and confirmed findings with ophthalmologists.

One thing I have learned is that the Spike protein from COVID-19 vaccination can cause a wide array of both bleeding and clotting abnormalities long after injection.

This may be worsened by intercurrent COVID-19 illness. Because of the widespread use of fibrinolytic and anticoagulant supplements (nattokinase, bromelain) and medicinal antiplatelet and anticoagulant drugs (aspirin, clopidogrel, apixaban, rivaroxaban, dabigatran, warfarin), I wondered if use of these agents was worsening the risk of bleeding in the eye among the vaccinated.

I found numerous reports of ocular hemorrhage after COVID-19 vaccination. Diabetes, prior cataract surgery, and injections for macular degeneration were cited as risk factors or co-incident conditions. It was interesting that not a single report cited an over-the-counter or prescription blood thinner as a contributing factor.

While all supplements and drugs have risks and benefits, I believe our usual and customary practice of warning patients concerning mucosal and major bleeding is reasonable.

The risks of clotting after vaccination far outweigh the risks of bleeding, and thus I will continue to recommend anticoagulant regimens in the appropriate clinical scenarios with bleeding caveats given to patients.

See more here Substack

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.